Celexorbio
Oakland, US · 1 known investors
Celexor Bio develops monoclonal antibody therapeutics targeting plasmacytoid dendritic cells to treat severe autoimmune and inflammatory disorders by interrupting the inflammatory cascade at its source. The company's lead candidate, CLXR-901, is designed to deplete pathological pDCs and modify disease progression in underserved patient populations.
Investors · 1
Competitors · 5
by search overlap
Exelixis6 shared keywordsExelixis is an oncology company that discovers and develops cancer treatments, including small molecule therapeutics and biotherapeutics such as antibody-drug conjugates, for patients across multiple tumor types. Its flagship commercial product is CABOMETYX (cabozantinib), and it operates through global development and commercialization partnerships.
Lexicon Pharmaceuticals5 shared keywords
Celldex Therapeutics, Inc.5 shared keywordsCelldex is a biotechnology company developing therapeutics across therapeutic areas including immunology and inflammation. The page shown is a board director biography rather than a company overview.
Lexeotx4 shared keywordsLEXEO Therapeutics develops gene therapy candidates aimed at genetically mediated cardiovascular diseases and APOE4-associated Alzheimer's disease. The clinical-stage company builds on research from Weill Cornell Medicine and the University of California San Diego.
Scilex Holding4 shared keywords
Companies competing with Celexorbio for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Celexorbio do?
- Celexor Bio develops monoclonal antibody therapeutics targeting plasmacytoid dendritic cells to treat severe autoimmune and inflammatory disorders by interrupting the inflammatory cascade at its source. The company's lead candidate, CLXR-901, is designed to deplete pathological pDCs and modify disease progression in underserved patient populations.
- Who are Celexorbio's investors?
- Celexorbio's investors include Aditum Bio.
- Where is Celexorbio headquartered?
- Celexorbio is headquartered in Oakland, US.